Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AXSM will decline by -2.95% over the next 2 Weeks and hit $201.68 by Tuesday, September 22, 2026. In that time frame, AXSM's share price is expected to range between $196.13 and $208.00.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 22, 2026 | 196.13 | 201.68 | 208.00 |
| Sep 21, 2026 | 196.83 | 202.69 | 208.32 |
| Sep 18, 2026 | 196.27 | 202.52 | 208.47 |
| Sep 17, 2026 | 199.26 | 205.56 | 211.77 |
| Sep 16, 2026 | 200.25 | 206.23 | 212.07 |
| Sep 15, 2026 | 199.09 | 204.74 | 210.31 |
| Sep 14, 2026 | 199.56 | 205.75 | 210.99 |
| Sep 11, 2026 | 200.25 | 205.58 | 211.16 |
| Sep 10, 2026 | 203.36 | 208.62 | 214.26 |
| Sep 9, 2026 | 203.30 | 209.29 | 215.10 |
AXSM shares rose +1.35% in Wednesday, September 9, 2026's trading session, rising from a previous close of $207.82 to move at $210.63. The stock demonstrated notable intraday movement (see AXSM's key stats for a full breakdown), fluctuating between $206.89 and $211.30, a +2.13% trading range. While recent weeks have seen some volatility, AXSM has managed to secure a +2.51% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 385.77K shares changing hands, 44.54K fewer than the previous session. This amounted to $81.25M in total market activity.
Will AXSM Continue Its Downward Trend?
According to analyst ratings and projections for AXSM, Axsome Therapeutics, Inc. shares are anticipated to decrease by -1.27%, potentially reaching $208.00 per share by September 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for AXSM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the AXSM stock forecast, now is not the best time to buy AXSM stock because its current trading price is +4.44% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AXSM covering social and institutional perspectives.
AXSM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AXSM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.44% to 53.69%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.05%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.16%, maintains a neutral outlook for the long term. Insights into AXSM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Axsome Therapeutics Short-Term Forecasts
AXSM Forecast For Next 5 Days
Our algorithm anticipates Axsome Therapeutics (AXSM) stock could hit $201.51 by Sep 16, 2026. This represents a -4.33% rise from today's price, following a +4.34% change over the past five days.
AXSM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Axsome Therapeutics, Inc. (AXSM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $186.46, which would mean a -11.48% decrease from the current price of $210.63. Projections for this period range from a high of $215.01 to a low of $158.36.
AXSM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Axsome Therapeutics's price over the next three months point to a rise. AXSM stock is expected to peak at $245.08 on Nov 10, 2026 after potentially dipping to $199.26 on Sep 11, 2026. On average, AXSM is likely to trade around $224.51 in the coming 90 days.
Axsome Therapeutics Stock Forecast 2025
Based on our predictive models, Axsome Therapeutics (AXSM) is expected to trade between $199.26 and $245.08 throughout 2026. This would result in an average price of $226.24, potentially offering investors a +7.41% return from current levels.
Axsome Therapeutics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in September 2026. The price is predicted to move between $199.26 and $229.44, settling at an average of $211.27. This could translate to a +0.30% gain.
October 2026
Based on current market signals, Axsome Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $207.40 to $235.95, with a likely average price of $224.68. Investors could expect a potential return of +6.67%.
November 2026
Our predictive algorithms indicate Axsome Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $211.47–$245.08, with an average target of $231.48. This represents a positive outlook and a possible gain of +9.90%.
December 2026
Analyzing established trends, Axsome Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $220.14 and $244.68, averaging around $233.37. This suggests a +10.80% gain from current levels.
January 2027
Market indicators suggest Axsome Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $216.72 to $237.42, with a midpoint forecast of $227.05. The stock might deliver a +7.80% gain.
February 2027
Forecasting for February 2027, models estimate that Axsome Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $216.74 and $245.05, averaging $229.97. This signals a positive trajectory with potential returns around +9.18%.
March 2027
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in March 2027. The price is predicted to move between $232.24 and $255.87, settling at an average of $244.84. This could translate to a +16.24% gain.
April 2027
Based on current market signals, Axsome Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $236.93 to $263.35, with a likely average price of $251.88. Investors could expect a potential return of +19.58%.
May 2027
Our predictive algorithms indicate Axsome Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $240.07–$264.78, with an average target of $253.21. This represents a positive outlook and a possible gain of +20.22%.
June 2027
Analyzing established trends, Axsome Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $235.65 and $257.98, averaging around $246.67. This suggests a +17.11% gain from current levels.
July 2027
Market indicators suggest Axsome Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $237.46 to $273.70, with a midpoint forecast of $251.36. The stock might deliver a +19.34% gain.
August 2027
Forecasting for August 2027, models estimate that Axsome Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $253.08 and $278.41, averaging $265.05. This signals a positive trajectory with potential returns around +25.84%.
September 2027
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in September 2027. The price is predicted to move between $259.74 and $281.49, settling at an average of $272.14. This could translate to a +29.20% gain.
AXSM's history of dividends and stock splits also plays a role in long-term investor confidence.

